Cargando…

Application of botulinum toxin to treat sialorrhea in amyotrophic lateral sclerosis patients: a literature review

Amyotrophic lateral sclerosis is a progressive and fatal neurodegenerative disease characterized by the degeneration of motor neurons, which are the central nervous system cells that control voluntary muscle movements. The excessive salivation (sialorrhea) is present in approximately 50% of amyotrop...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Oliveira, Ademar Francisco, Silva, Gêssyca Adryene de Menezes, Almeida, Débora Milenna Xavier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Instituto Israelita de Ensino e Pesquisa Albert Einstein 2016
Materias:	Reviewing Basic Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5234759/ https://www.ncbi.nlm.nih.gov/pubmed/27759834 http://dx.doi.org/10.1590/S1679-45082016RB3594

Ejemplares similares

Efficacy of Botulinum Toxin for Treating Sialorrhea in Neuromuscular Conditions
por: Singh, Harsh, et al.
Publicado: (2020)

Using Intensity Modulated Radiation Therapy for the Treatment of Sialorrhea in Amyotrophic Lateral Sclerosis
por: Ati, Shomik, et al.
Publicado: (2022)

Sialorrhea: Anatomy, Pathophysiology and Treatment with Emphasis on the Role of Botulinum Toxins
por: Lakraj, Amanda Amrita, et al.
Publicado: (2013)

Botulinum toxin in the treatment of sialorrhea in severe neurological patients with tracheotomy
por: Shao, Mengmeng, et al.
Publicado: (2023)

Therapy of Sialorrhea with Botulinum Neurotoxin
por: Jost, Wolfgang H., et al.
Publicado: (2019)

Botulinum Toxin A in the Management of Pediatric Sialorrhea: A Systematic Review
por: Heikel, Tiffany, et al.
Publicado: (2022)

Application of botulinum toxin to reduce the saliva in patients with amyotrophic lateral sclerosis
por: Manrique, Dayse
Publicado: (2015)

Effectiveness of the Botulinum Toxin for Treating Sialorrhea in Patients with Parkinson’s Disease: A Systematic Review
por: Ruiz-Roca, Juan Antonio, et al.
Publicado: (2019)

Effect of Botulinum Toxin A Injection into the Salivary Glands for Sialorrhea in Children with Neurologic Disorders
por: Jeung, In Seuk, et al.
Publicado: (2012)

A 10-year Retrospective Review of Botulinum Toxin Injections and Surgical Management of Sialorrhea
por: Weitzman, Rachel E, et al.
Publicado: (2020)

Botulinum Toxin Type A and Physiotherapy in Spasticity of the Lower Limbs Due to Amyotrophic Lateral Sclerosis
por: Marvulli, Riccardo, et al.
Publicado: (2019)

The effectiveness and safety of botulinum toxin injections for the treatment of sialorrhea with Parkinson's disease: a systematic review and meta-analysis
por: Yang, Chun-Lan, et al.
Publicado: (2023)

Comparative Efficacy of Botulinum Toxin in Salivary Glands vs. Oromotor Therapy in the Management of Sialorrhea in Cerebral Palsy Impact on Sleep Quality
por: Marquez-Vazquez, Juan Francisco, et al.
Publicado: (2022)

Ultrasound Guidance Superiority in Pediatric Sialorrhea Treatment With Intraglandular Botulinum Toxin Application: A Four-Year Retrospective Study
por: Pires, Mafalda, et al.
Publicado: (2023)

2219: Amyotrophic lateral sclerosis, stem cells and TALENted technology
por: Kurani, Shaheen, et al.
Publicado: (2018)

Sialorrhea in Parkinson’s Disease
por: Isaacson, Jonathan, et al.
Publicado: (2020)

Lithium-Induced Sialorrhea
por: Johnson, Bamidele O, et al.
Publicado: (2023)

A Double-Blind Randomized Controlled Trial Investigating the Most Efficacious Dose of Botulinum Toxin-A for Sialorrhea Treatment in Asian Adults with Neurological Diseases
por: Mazlan, Mazlina, et al.
Publicado: (2015)

Fatigue in amyotrophic lateral sclerosis and correlated factors
por: Alencar, Mariana Asmar, et al.
Publicado: (2022)

Sensory Involvement in Amyotrophic Lateral Sclerosis
por: Rubio, Miguel A., et al.
Publicado: (2022)

Amyotrophic lateral sclerosis
por: Wijesekera, Lokesh C, et al.
Publicado: (2009)

Lipid Biomarkers for Amyotrophic Lateral Sclerosis
por: González De Aguilar, Jose-Luis
Publicado: (2019)

Amyotrophic Lateral Sclerosis: New Perpectives and Update
por: Orsini, Marco, et al.
Publicado: (2015)

Dealing With Clozapine-Induced Sialorrhea
por: Sá Couto, J., et al.
Publicado: (2022)

The Cyanobacteria Derived Toxin Beta-N-Methylamino-L-Alanine and Amyotrophic Lateral Sclerosis
por: Banack, Sandra Anne, et al.
Publicado: (2010)

Skeletal muscle in amyotrophic lateral sclerosis
por: Shefner, Jeremy M, et al.
Publicado: (2023)

Amyotrophic lateral sclerosis and neuroregeneration
Publicado: (2012)

Mimickers of Amyotrophic Lateral Sclerosis
por: Dubey, Ayush, et al.
Publicado: (2019)

Destination Amyotrophic Lateral Sclerosis
por: Keon, Matt, et al.
Publicado: (2021)

Prionoids in amyotrophic lateral sclerosis
por: Gosset, Philippe, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis and cerebellum
por: Kabiljo, Renata, et al.
Publicado: (2022)

Dysautonomia in Amyotrophic Lateral Sclerosis
por: Oprisan, Alexandra L., et al.
Publicado: (2023)

Cerebrospinal Fluid Chitinases as Biomarkers for Amyotrophic Lateral Sclerosis
por: Costa, Júlia, et al.
Publicado: (2021)

In silico analysis of PFN1 related to amyotrophic lateral sclerosis
por: Pereira, Gabriel Rodrigues Coutinho, et al.
Publicado: (2019)

Retromer dysfunction in amyotrophic lateral sclerosis
por: Pérez-Torres, Eduardo J., et al.
Publicado: (2022)

Motoneuron firing in amyotrophic lateral sclerosis (ALS)
por: de Carvalho, Mamede, et al.
Publicado: (2014)

Phenotypic heterogeneity in amyotrophic lateral sclerosis type 8 and modifying mechanisms of neurodegeneration
por: Oliveira, Danyllo, et al.
Publicado: (2021)

Basal ganglia alterations in amyotrophic lateral sclerosis
por: Castelnovo, Veronica, et al.
Publicado: (2023)

The Role of Skeletal Muscle in Amyotrophic Lateral Sclerosis
por: Loeffler, Jean‐Philippe, et al.
Publicado: (2016)

SIALORRHEA AND XEROSTOMIA IN PARKINSON’S DISEASE PATIENTS
por: Špiljak, Bruno, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cdcl58ef6uguhvoj0eqmes76eu